Assertio Holdings Inc Acquisition of Spectrum Pharmaceuticals Inc - M&A Call Transcript
Good morning, and welcome to the Assertio Holdings, Inc. and Spectrum Pharmaceuticals, Inc. Conference Call. (Operator Instructions) Please note that this event is being recorded. I would now like to turn the conference over to Matt Kreps from Darrow Associates, Investor Relations for Assertio. Please go ahead.
Thank you, Brianna. Good morning, and thank you to all of you for joining us on this special conference call regarding the definitive agreement announced earlier today, pursuant to which Assertio will acquire all outstanding shares of Spectrum and all stock and contingent value rights transaction. The joint press release with details of the agreement is now available on the investor pages of both companies. I would encourage you to review the release and related SEC filings. With me today are Dan Peisert, President and CEO of Assertio and Tom Riga, President and CEO of Spectrum. After prepared remarks from Dan and Tom, we will open the call for your questions. During this call, management will make
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |